--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "VISPro - VIS Calculator" developer_entity: "Readfeed, Inc." bundle_id: "com.readfeed.vispro" app_store_id: "6760238459" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "N/A" report_date: "2026-04-01" report_version: "N/A" total_reviews: 0 confidence: "low" confidence_score: 0 data_age_days: 75 intelligence_version: 2 tags: ["medical", "paid", "mobile app", "app review", "app analysis", "medical", "professionals,", "intensivists,"] canonical_url: "https://marlvel.ai/apps/com-readfeed-vispro" license: "CC-BY-NC 4.0" last_verified: "2026-04-18T00:21:48.285Z" --- # VISPro - VIS Calculator App Audit > **TL;DR:** VISPro - VIS Calculator is a medical app by Readfeed, Inc., available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** VISPro - VIS Calculator is a medical app by Readfeed, Inc.. ## Metadata & Market Performance - **Publisher:** Readfeed, Inc. - **Category:** Medical - **Target Audience:** Medical professionals, such as intensivists, anesthesiologists, and critical care nurses, who require quick bedside calculations for vasoactive medication support. - **Platforms:** iOS - **Version Audited:** N/A - **Audit Date:** 2026-04-01 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0/1.0) - **App Store ID (iOS):** 6760238459 - **Bundle ID:** com.readfeed.vispro - **Data Window:** Analysis based on signals collected up to 2026-04-01 ## Executive Snapshot VISPro is a specialized medical utility designed for critical care professionals, including intensivists, anesthesiologists, and critical care nurses. Its primary value proposition is providing a streamlined, point-of-care tool for calculating the Vasoactive-Inotropic Score (VIS), a critical metric for quantifying cardiovascular support in patients. Positioned within the Medical category, the app adopts a low-friction, one-time purchase model ($0.99). This strategy targets professionals seeking a reliable, ad-free, and dedicated tool without the commitment of a recurring subscription. The app has recently entered the market, debuting at #31 in the Paid Medical category (US), indicating an immediate, albeit niche, interest from the medical community. ## App DNA (Features & Intent) - **[Standard] VIS Calculation:** Calculates the Vasoactive-Inotropic Score (VIS), a clinical tool used to quantify the amount of cardiovascular support a patient is receiving. ## Monetization Strategy - **Model:** Paid - **Tiers:** One-time purchase at $0.99 - **Price:** iOS: $0.99 - **Analysis:** The app utilizes a low-cost, one-time purchase model, positioning itself as a utility tool for medical professionals rather than a subscription-based service. ## SWOT Analysis **Core Strengths:** - Focused utility solving a specific clinical problem - Low $0.99 price point reduces friction for professional users - Professional-grade positioning **Critical Frictions:** - Zero social proof (no ratings/reviews) - Single-feature limitation - Lack of digital footprint (no website/socials) **Growth Levers:** - Expansion into a broader suite of critical care calculators - Content marketing to capture professional search traffic - Potential integration with clinical reference platforms **Market Threats:** - Dominance of established, free, multi-tool medical apps - Maintenance overhead vs. low revenue potential - Low barrier to entry for competitors to replicate the calculation ## The "So What?" (Strategic Takeaway) {#so-what} VISPro - VIS Calculator is an established medical app that is a paid app. **Strategic Opportunity:** While VISPro - VIS Calculator benefits from focused utility solving a specific clinical problem, its vulnerability lies in zero social proof (no ratings/reviews). A challenger could exploit this by focusing on expansion into a broader suite of critical care calculators. **Best for:** Medical professionals, such as intensivists, anesthesiologists, and critical care nurses, who require quick bedside calculations for vasoactive medication support. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Paid | | Platforms | iOS | | Key Features | 1 analyzed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **VISPro - VIS Calculator** (this app) | N/A/5 | N/A | Readfeed, Inc. | | [Vulvar Pain Algorithm](https://marlvel.ai/apps/com-washgyn-vestibulodynia) | N/A/5 | N/A | Jennifer Lanoff | | [Total Reflexology-3D](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) | 4.0/5 | N/A | GraphicVizion | | [CardioGenetics](https://marlvel.ai/apps/com-scd-risk-calculator) | N/A/5 | N/A | MARK EMILE PEPIN | | [ECGsource](https://marlvel.ai/apps/com-ecgsource-applicationname) | 3.0/5 | N/A | ECGsource LLC | | [My F1rst Steps](https://marlvel.ai/apps/com-myfirststeps-www) | 5.0/5 | N/A | My First Steps LLC | ## Company Profile - **Developer:** Readfeed, Inc. ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/vispro-vis-calculator/id6760238459?uo=2) - **Sources:** App store metadata. ## Related Intel Reports - [*Vulvar Pain Algorithm*](https://marlvel.ai/apps/com-washgyn-vestibulodynia) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Total Reflexology-3D*](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) (GraphicVizion) — 4.0/5 Rating | N/A Sentiment - [*CardioGenetics*](https://marlvel.ai/apps/com-scd-risk-calculator) (MARK EMILE PEPIN) — N/A Rating | N/A Sentiment - [*ECGsource*](https://marlvel.ai/apps/com-ecgsource-applicationname) (ECGsource LLC) — 3.0/5 Rating | N/A Sentiment - [*My F1rst Steps*](https://marlvel.ai/apps/com-myfirststeps-www) (My First Steps LLC) — 5.0/5 Rating | N/A Sentiment - [*Mobile VSO : Claims Guide*](https://marlvel.ai/apps/app-replit-mobilevso) (ANDREW THOMAS COOLEY) — 5.0/5 Rating | N/A Sentiment - [*Pelvic Pain Pentad*](https://marlvel.ai/apps/com-pentad-app) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Protectometer*](https://marlvel.ai/apps/protectometer) (noigroup) — 2.0/5 Rating | N/A Sentiment - [*Drug Facts by PillSync.com*](https://marlvel.ai/apps/drug-facts-by-pillsync-com) (Scanidme inc) — 4.3/5 Rating | Positive Sentiment - [*Beat Social Phobia with AJ*](https://marlvel.ai/apps/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline: 1. **Feature & Positioning Extraction** — Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning. 2. **Sentiment Analysis** — Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes. 3. **Intelligence Synthesis** — Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights. - **Confidence Score:** 0/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 75 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-readfeed-vispro) Data licensed for AI Agent attribution under CC-BY-NC 4.0.